NewAmsterdam Pharma Co N.V (NAMS) Current Leases: 2022-2025
Historic Current Leases for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Sep 2025 value amounting to $181,000.
- NewAmsterdam Pharma Co N.V's Current Leases fell 24.58% to $181,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $181,000, marking a year-over-year decrease of 24.58%. This contributed to the annual value of $246,000 for FY2024, which is 310.00% up from last year.
- As of Q3 2025, NewAmsterdam Pharma Co N.V's Current Leases stood at $181,000, which was down 19.56% from $225,000 recorded in Q2 2025.
- NewAmsterdam Pharma Co N.V's 5-year Current Leases high stood at $252,000 for Q1 2025, and its period low was $43,000 during Q1 2024.
- Moreover, its 3-year median value for Current Leases was $229,500 (2024), whereas its average is $185,125.
- Examining YoY changes over the last 5 years, NewAmsterdam Pharma Co N.V's Current Leases showed a top increase of 486.05% in 2025 and a maximum decrease of 24.58% in 2025.
- Quarterly analysis of 4 years shows NewAmsterdam Pharma Co N.V's Current Leases stood at $66,000 in 2022, then dropped by 9.09% to $60,000 in 2023, then spiked by 310.00% to $246,000 in 2024, then decreased by 24.58% to $181,000 in 2025.
- Its Current Leases was $181,000 in Q3 2025, compared to $225,000 in Q2 2025 and $252,000 in Q1 2025.